Products for Research Use Only

Human ASPA Protein

CAT: 0952-B2011795Size: 100 µgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0952-B2011795Size:100 µg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Human ASPA Protein_x000D_ Catalog number: B2011795_x000D_ Lot number: Batch Dependent_x000D_ Expiration Date: Batch dependent_x000D_ Amount: 100 µg_x000D_ Molecular Weight or Concentration: 500 µg/mL_x000D_ Supplied as: Solution_x000D_ Applications: molecular tool for various biochemical applications_x000D_ Storage: -20 °C_x000D_ Keywords: ASP protein, Aspartoacylase protein, ACY2 protein_x000D_ Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ References:_x000D_ 1: Galván-Román JM, Rodríguez-García SC, Roy-Vallejo E, Marcos-Jiménez A, Sánchez-Alonso S, Fernández-Díaz C, Alcaraz-Serna A, Mateu-Albero T, Rodríguez-Cortes P, Sánchez-Cerrillo I, Esparcia L, Martínez-Fleta P, López-Sanz C, Gabrie L, Del Campo Guerola L, Suárez-Fernández C, Ancochea J, Canabal A, Albert P, Rodríguez-Serrano DA, Aguilar JM, Del Arco C, de Los Santos I, García-Fraile L, de la Cámara R, Serra JM, Ramírez E, Alonso T, Landete P, Soriano JB, Martín-Gayo E, Fraile Torres A, Zurita Cruz ND, García-Vicuña R, Cardeñoso L, Sánchez-Madrid F, Alfranca A, Muñoz-Calleja C, González-Álvaro I; REINMUN-COVID Group. IL-6 serum levels predict severity and response to tocilizumab in COVID-19: An observational study J Allergy Clin Immunol. 2021 Jan;147(1):72-80.e8._x000D_ 2: Ibraheim R, Tai PWL, Mir A, Javeed N, Wang J, Rodríguez TC, Namkung S, Nelson S, Khokhar ES, Mintzer E, Maitland S, Chen Z, Cao Y, Tsagkaraki E, Wolfe SA, Wang D, Pai AA, Xue W, Gao G, Sontheimer EJ. Self-inactivating, all-in-one AAV vectors for precision Cas9 genome editing via homology-directed repair in vivo Nat Commun. 2021 Nov 1;12(1):6267._x000D_ 3: Gersing SK, Wang Y, Grønbæk-Thygesen M, Kampmeyer C, Clausen L, Willemoës M, Andréasson C, Stein A, Lindorff-Larsen K, Hartmann-Petersen R. Mapping the degradation pathway of a disease-linked aspartoacylase variant PLoS Genet. 2021 Apr 29;17(4):e1009539._x000D_ 4: Sommer A, Sass JO. Expression of aspartoacylase (ASPA) and Canavan disease Gene. 2012 Sep 1;505(2):206-10._x000D_ 5: Hall M, Nylander S, Jenkinson HF, Persson K. Structure of the C-terminal domain of AspA (antigen I/II-family) protein from Streptococcus pyogenes FEBS Open Bio. 2014 Mar 12;4:283-9._x000D_ 6: Yang H, Brown RH Jr, Wang D, Strauss KA, Gao G. AAV-Mediated Gene Therapy for Glycosphingolipid Biosynthesis Deficiencies Trends Mol Med. 2021 Jun;27(6):520-523._x000D_ 7: Pleasure D, Guo F, Chechneva O, Bannerman P, McDonough J, Burns T, Wang Y, Hull V. Pathophysiology and Treatment of Canavan Disease Neurochem Res. 2020 Mar;45(3):561-565._x000D_ 8: Franklin L, Nobbs AH, Bricio-Moreno L, Wright CJ, Maddocks SE, Sahota JS, Ralph J, O'Connor M, Jenkinson HF, Kadioglu A. The AgI/II family adhesin AspA is required for respiratory infection by Streptococcus pyogenes PLoS One. 2013 Apr 30;8(4):e62433._x000D_ 9: Xu C, Jiang Y, Huang J, Huang J, Pu K. Second Near-Infrared Light-Activatable Polymeric Nanoantagonist for Photothermal Immunometabolic Cancer Therapy Adv Mater. 2021 Sep;33(36):e2101410._x000D_ 10: Hershfield JR, Madhavarao CN, Moffett JR, Benjamins JA, Garbern JY, Namboodiri A. Aspartoacylase is a regulated nuclear-cytoplasmic enzyme FASEB J. 2006 Oct;20(12):2139-41. _x000D_ _x000D_ Products Related to Human ASPA Protein can be found at Proteins
Short Description
Catalog Number: B2011795 (100 µg)
Weight
0.15
Length
2
Width
0.5
Height
0.5